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Abstract
Background: Authors and colleagues have undertaken clinical research on Carbohydrate (CR) and Low Carbohydrate Diet (LCD) for years. We have proposed 
new evaluation method of insulinogenic index-carbohydrate 70g (IGI-carbo70). In similar way, C-peptide index for Carbohydrate-70 (CPI-Carbo70) is proposed 
in this report.
Subjects and methods: The subjects were 37 patients with Type 2 diabetes mellitus (T2DM) and admitted for further evaluation and treatment. CR diet was provided 
on day 1 and 2, including 60% carbohydrates, 25% lipids and 15% protein with 1400 kcal/day. On day 2, breakfast with 70g of carbohydrate was provided, and glucose 
and C-peptide values were measured at 0 and 30 minutes. 
Results: Average HbA1c was 8.1 %, and Morbus (M) value was 70.5 in median. Glucose and C-peptide on 0--30min significantly increased as 163--195 mg/dL, 
1.1--1.5μU/mL, respectively. CPI-Carbo70 was 1.94 in average and 1.54 in median. There were significant correlations between increments of glucose and C-peptide, 
and between HbA1c and CPI-Carbo70.
Discussion and conclusion: CPI-Carbo70 was investigated and proposed. It may be useful for evaluating the function of the pancreas. This research would give the 
fundamental data for this field, and further research development will be expected in the future.
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Introduction
Diabetes has been a medical and social serious problem in the 
world. Its number of diabetic patients is increasing and about 425 
million, including 30 million in United States, 73 million in India and 
110 million in China [1]. The cause related to this situation include 
various factors such as endocrine / metabolic impairment, obesity, 
changing meal and lifestyle with aging [2].
Then, there have been various comments concerning diabetes 
guidelines. Recently, the American College of Physicians (ACP) 
presented official comments concerning diabetes [3]. Among them, 
rather surprising statement was found that clinicians should set the 
management goal for HbA1c in most type 2 diabetic patients to be 7% 
or more and less than 8%. It has made a paradigm change for diabetic 
treatment.
On contrast, American Diabetes Association (ADA) released 
comments about goals and treatment for diabetes associated with 
complications of cardiovascular disease and the prevention of 
recurrence in the treatment for diabetes [4].
As to nutrition therapy for diabetes, there are continuing discussion 
concerning Calorie Restriction (CR) and Low Carbohydrate Diet 
(LCD) for years [5-8]. Atkins and Bernstein originally have begun to 
introduce LCD [9,10]. After that, clinical predominance of LCD has 
been gradually known and more prevalent in European and North-
American region. On contrast in Japan, authors and colleagues have 
started LCD, and reported thousands of cases with clinical efficacy 
[11,12]. Moreover, we have investigated related research concerning 
LCD formula meals, elevated ketone bodies, Morbus (M) value, lipid 
metabolism and renal function [13-15].
We have undertaken clinical research on CR and LCD meals 
in a series of studies. Among them, a breakfast containing 70 
g of carbohydrate was administered instead of 75 g of glucose, 
and the reaction of blood glucose and insulin (immunoreactivity 
insulin, IRI) was studied. As a result, insulinogenic index (IGI) 
for Carbo 70 was reported on insulin response to Carbo 70 [16]. 
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  Along the similar method of clinical research for Carbo70, we have 
studied the responses of blood glucose and C-peptide to Carbo 70 and 
describe in this paper.
Subjects and methods
The subjects who were enrolled in this study were 37 patients 
(M/F 15/22) with Type 2 diabetes mellitus (T2DM). Their ages were 
35-80 years old, with 62.5 years old in average. Diabetic subjects were 
admitted for 14 days for further evaluation and treatment of T2DM. 
They were on the protocol of diet therapy as in-patients. 
Methods included in the following steps. 1) Calorie Restriction 
(CR) diet was given for the subjects on day 1 and 2. CR had 60% 
carbohydrates, 25% lipids and 15% protein with 1400 kcal/day. 2) Low 
Carbohydrate Diet (LCD) was given from 3 to 14 days, which had 12% 
carbohydrates, 64% lipids and 24% protein with 1400 kcal/day. This 
meal of LCD has been so-called “super-LCD formula” in our research 
for years, which is one of the Very low-carbohydrate ketogenic diet 
(VLCKD) by the definitions of LCD [17-19]. 
Thus, both protocol with CR and LCD was continued for years in 
our clinical research. However, in current study, we have used only 
the breakfast on day 2. CR meal includes 840kcal of carbohydrate per 
day, which equals totally 210g of carbohydrate in 3 meals, according 
to the nutrients balance of PFC (protein, fat, carbohydrate) from the 
guideline of Japan Diabetes Society [20]. Then, breakfast including 70g 
of carbohydrate was provided to the patients after overnight fasting.
The detail of the examination is as follows: 1) basal biomarkers were 
measured in fasting on day 2, 2) blood glucose and C-peptide value 
were measured before breakfast (0 min), 3) patients has taken breakfast 
with 70g of carbohydrate, 4) glucose and C-peptide were measured 30 
minutes after breakfast, 5) values of 0 min, 30 min and increment of 
glucose and C-peptide were measured, 6) index of ratio for increment of 
C-peptide / glucose which is CPI-Carbo70 was calculated and analyzed.
Daily glucose profile and Morbus value
As to daily glucose profile on day 2, we measured blood glucose 
7 times a day, which are 8, 10, 12, 14, 17, 19, 22h. From these data, 
2 biomarkers were calculated, which are average glucose level and M 
value. 
M value has been known as the one of the useful index indicating 
both blood sugar level and mean amplitude of glycemic excursions 
(MAGE) [21-23]. When investigating glucose variability, daily profiles 
of blood glucose was measured, and average glucose level and M value 
can be calculated. M value has been formerly proposed for researching 
the status of MAGE. This index has been calculated as a logarithmic 
transformation of the deviation of glycemia from an arbitrary assigned 
“ideal” glucose value. It can express both the mean glucose value and 
the effect of glucose swings [21-24].
The formula of M value is defined as follows: M = MBS + MW, 
where MW = (maximum blood glucose − minimum glucose)/20; MBS 
= the mean of MBSBS; MBSBS = individual M-value for each blood 
glucose value calculated as (absolute value of [10 × log (blood glucose 
value/120)])3. It can be understood by the equation [21-24].
In the case of interpretation of M value, the standard range has 
been <180, with borderline 180-320 and abnormal >320. Formerly, 
ideal sampling times a day has been in discussion. Through several 
experimental research, it had showed similar results on 7 times or 20 
times per day [21-23,25]. It also showed similar result in comparison 
with continuous glucose monitoring (CGM) [23,25,26].
Statistical analyses
Obtained data in current study were represented as the mean 
+/- standard deviation (SD) and also represented median, quartile of 
25% and 75% in the results of biomarkers. For performing statistical 
analyses, correlation coefficients were calculated by using Spearman 
test of the Microsoft Excel analytical tool widely used, which is Four 
steps Excel Statistics 4th edition [27].
Ethical considerations
Present study was conducted in compliance with the ethical 
principles of the Declaration of Helsinki. It was also conducted with 
Japan’s Act on the Protection of Personal Information along with the 
Ministerial Ordinance on Good Clinical Practice (GCP) for Drug 
(Ordinance of Ministry of Health and Welfare No. 28 of March 27, 
1997). Moreover, we have established an ethical committee including 
doctor, nurse, pharmacist and expert in the medical/legal specialty. 
We have discussed and made confirmation that this study is valid and 
agreed with all members without any problems. Furthermore, informed 
consents and written paper agreements have been obtained from the 
subjects. The study was registered with UMIN #R000031211.
Results
1) Basal data
This study enrolled 37 patients of T2DM. Their basal data were 
summarized in Table 1. Values are expressed by average and standard 
deviation, and also by median [25% - 75%]. The average age was 62.5 
years old, with 65 years old in median. Data of HbA1c was 8.1 % in 
average and 7.7% in median. M value calculated from the daily profile 
of glucose on day 2 was 70.5 [43.2 – 203] (median [25 % - 75 %]).
2) Carbohydrate loading
  mean ± SD median [25% - 75%]
Subjects    
 number of cases 37 37
 sex (male/female) 15/22 15/22
 age (years old) 62.5 ± 10.9 65 [55 - 68]
Glucose profile    
 HbA1c (%) 8.1 ± 1.8 7.7 [ 7.0 - 9.2]
 average glucose (mg/dL) 203.7 ± 71.2 187 [161 - 228]
 Morbus value 186.5 ± 256.1 70.5 [43.2 - 203]
Table 1. Subjects and basal data
  mean ± SD median [25% - 75%]
Response of blood 
glucose    
 glucose- 0 min (mg/dL) 162.5 ± 54.9 142 [134 - 186]
 glucose-30 min (mg/dL) 194.7 ± 65.2 186 [155 - 214]
 increment (⊿) (mg/dL) 32.2 ± 26.4 22 [13 - 46]
Response of 
C-peptide    
 C-peptide- 0 min (ng/mL) 1.08 ± 0.65 0.9 [0.7 - 1.4]
 C-peptide-30 min (ng/mL) 1.52 ± 0.83 1.4 [1.0 - 1.9]
 increment (⊿) (ng/mL) 0.44 ± 0.41 0.4 [0.2 - 0.5]
Index of C-peptide 
for carbo-70    
 ⊿CPR/⊿BG 1.94 ± 1.51 1.54 [0.83 - 2.5]
Table 2. Responses of Glucose and C-peptide for Carbo-70
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Changes in biomarkers data in response to 70g of carbohydrate 
intake were shown in Table 2. The values included blood glucose and 
C-peptide in 0 and 30 min. Data are expressed by the average, standard 
deviation, median and quartile of 25% and 75%.
3) Correlation among HbA1c, glucose and M value
Mutual correlations among HbA1c, average blood glucose and 
M value were investigated. Average blood glucose and M value were 
calculated from 7 points of daily blood glucose levels. There was 
significant correlation between average glucose and HbA1c (p<0.01) 
(Figure 1). Similarly, there was significant correlation between average 
blood glucose and M value (p<0.01) (Figure 2).
4) Correlation among HbA1c, glucose and M value
Correlation of increments of glucose and C-peptide for Carbo70 
is shown in Figure 3. Both factors revealed significant correlation 
(p<0.01). There was significant negative correlation between HbA1c 
value and CPI-Carbo70 (Figure 4).
Discussion
We have been investigating research concerning M value in CR and 
LCD and related clinical studies. In this study, significant correlation 
was found between HbA1c and mean blood glucose, and between mean 
blood glucose and M value. This result would indicate the adequate 
validity of evaluation method using these three biomarkers. 
The response of insulin and C-peptide to GTT and insulinogenic 
index (IGI) studies are found to evaluate the function of the pancreas in 
diabetes [28]. Peak C-peptide for GTT seems to be at 30 min in healthy 
young and 60 min in healthy elderly [29]. All non-diabetic control 
subjects showed a peak of at least 6.5 ng/ml and an increment of at least 
4 ng/ml. Ratio of C-peptide increment / glucose increment at 0-30 min. 
was inversely related to the prevailing fasting blood glucose (FBG) [29].
In clinical practice for diabetes, Insulinogenic index (IGI) has been 
one of the simple and useful marker calculating the ratio of insulin 
increment to glucose increment in 75g OGTT at 30min [30]. Recent 
study revealed that the average IGI was 1.00, 0.69 and 0.46 in 3 groups, 
including normal glucose tolerance (NGT), group with fasting glucose 
100-109 mg/dL, group with fasting glucose 110-125 mg/dL, respectively 
[31]. In the case of T2DM with and without aggravation of parameters, 
IGI in average was showed 0.3 and 0.5, respectively [32].
There is a famous fast food named Gyudon, which is a rice bowl 
topped with beef. Glucose response to eating Gyudon was studied. It 
has protein 18.4g, fat 20.9g and carbohydrate 82.9g, which was given to 
12 healthy volunteers with 26.9 years old in average [33]. Blood glucose 
increased 65 mg/dL at 30min in average. Thus, even if the subjects are 
healthy, blood glucose increase seems to be remarkable for taking 82.9g 
of carbohydrate.
In this analysis, there was a significant correlation between rise 
in blood sugar for Carbo 70 and rise in C-peptide, and a significant 
correlation was also found between HbA1c value and CPI-Carbo70. 
From this result and other previous related papers, it seems to be useful 
to investigate insulin response and pancreatic function by the load of 
Carbo 70 instead of 75 g glucose.
 
Figure 1. Correlation between average blood glucose and HbA1c.
There was significant correlation between them (p<0.01).
 
Figure 2. Correlation between Morbus value and average blood glucose. 
There was significant correlation between them (p<0.01).
 
Figure 3. Correlation between increment of blood glucose and increment of CP 
Significant correlation was observed between them (p < 0.01).
 
Figure 4. Correlation between HbA1c and CP index for carbo70
Significant correlation was observed between them (p < 0.05).
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This research would have some limit as follows; 1) both response of 
IRI and C-peptide were not measured simultaneously, 2) meal includes 
not only carbohydrate but also protein and lipids, which may influence 
the response of glucose and c-peptide, 3) the function of ingestion and 
absorption would also influence the response. 
Conclusion
In this report, the response of C-peptide and CPI-Carbo70 were 
described and proposed. As an alternative examination for 75 g OGTT, 
CPI-Carbo70 may be simple and useful for evaluating the function of 
the pancreas. This research would give the fundamental data for this 
field, and further research development will be expected in the future.
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